These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 24950812)

  • 21. The differences in immunizing capacity between various tetanus toxoids in active-passive immunization with human antitoxin.
    Cohen H; Peetoom F; van Ramshorst JD
    Prog Immunobiol Stand; 1970; 4():527-32. PubMed ID: 5482197
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical tetanus despite a protective level of toxin-neutralizing antibody.
    Passen EL; Andersen BR
    JAMA; 1986 Mar; 255(9):1171-3. PubMed ID: 2868135
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on mother-child immunity of tetanus. 2. Vicissitudes of tetanus passive antibody in the blood of newborn infants obtained by immunizing the mother and the result of tetanus active immunity in such cases].
    Koda T
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):367-71. PubMed ID: 6070600
    [No Abstract]   [Full Text] [Related]  

  • 24. [The distribution and elimination of intralumbarly administered homologous tetanus antitoxin. Immunological and physico-chemical studies of the cerebrospinal fluid and serum of tetanus patients after lumbar administration of human tetanus hyperimmune globulin].
    Auerswald W; Binder B; Doleschel W; Krenn J; Mlczoch J; Müller H; Steinbereithnerk
    Klin Wochenschr; 1970 Nov; 48(21):1312-4. PubMed ID: 5537846
    [No Abstract]   [Full Text] [Related]  

  • 25. [Observation of immunity level of pertussis-diphtheria-tetanus in healthy people in Hangzhou City during 1995-2006].
    Huang LM; Xu EP; Yang LX
    Zhongguo Yi Miao He Mian Yi; 2009 Feb; 15(1):68-71. PubMed ID: 20077681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Studies on mother-child immunity of tetanus. 1. Effect of tetanus toxoid injection on the maternal body in pregnancy].
    Koda T
    Nihon Shonika Gakkai Zasshi; 1967 Mar; 71(3):361-6. PubMed ID: 6070599
    [No Abstract]   [Full Text] [Related]  

  • 27. [The possible mechanism of the formation of antitoxic immunity to tetanus as a result of a blood transfusion].
    Korableva NN; Khors NP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Apr; (4):84-6. PubMed ID: 1882615
    [No Abstract]   [Full Text] [Related]  

  • 28. An attempt at using a monospecific tetanus antitoxin as a national reference preparation for flocculation tests.
    Vrancheva S; Valchev V; Gakev V; Bachev S
    Prog Immunobiol Stand; 1967; 3():341-5. PubMed ID: 4985513
    [No Abstract]   [Full Text] [Related]  

  • 29. Tetanus--forgotten but not gone.
    Sanford JP
    N Engl J Med; 1995 Mar; 332(12):812-3. PubMed ID: 7862186
    [No Abstract]   [Full Text] [Related]  

  • 30. [Certain groups of the population are still without protection against tetanus--the diagnosis must be considered].
    Johansson PJ; Blomquist S
    Lakartidningen; 1992 May; 89(19):1667-9. PubMed ID: 1579035
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunologic tests: Clostridium tetani].
    Takahashi M
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():206-9. PubMed ID: 16111228
    [No Abstract]   [Full Text] [Related]  

  • 32. Seroepidemiologic study on pertussis, diphtheria, and tetanus in the Fukuoka area of southern Japan: seroprevalence among persons 0-80 years old and vaccination program.
    Okada K; Ueda K; Morokuma K; Kino Y; Tokugawa K; Nishima S
    Jpn J Infect Dis; 2004 Apr; 57(2):67-71. PubMed ID: 15118214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [On the problem of the use of homologous tetanus antitoxins in the treatment of severe tetanus: clinical and immunologic studies following treatment with human tetanus-hyperimmunoglobulin].
    Auerswald W; Brücke P; Kucher R; Marsoner F; Müller H; Seidl H; Steinbereithner K; Wagner E
    Wien Med Wochenschr; 1966 Mar; 116(11):229-35. PubMed ID: 4168478
    [No Abstract]   [Full Text] [Related]  

  • 34. Quantification of tetanus antitoxin in human sera. II. Comparison of counter-immunoelectrophoresis and passive haemagglutination with toxin neutralization in mice.
    Winsnes R; Christiansen G
    Acta Pathol Microbiol Scand B; 1979 Jun; 87B(3):197-200. PubMed ID: 474133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tetanus immunity in individuals aged 50 years or older in Kashan, Iran.
    Razzaghi R; Khalifesoltani A; Heravi MM; Akbari H
    Acta Med Iran; 2011; 49(6):379-82. PubMed ID: 21874642
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tolerance and effectiveness of tetanus immunoglobulin with special reference to simultaneous prevention].
    Harrfeldt HP
    Dtsch Med Wochenschr; 1972 Mar; 97(10):364-8. PubMed ID: 5011481
    [No Abstract]   [Full Text] [Related]  

  • 37. High tetanus antitoxin antibody concentrations in the Netherlands: a seroepidemiological study.
    Steens A; Mollema L; Berbers GA; van Gageldonk PG; van der Klis FR; de Melker HE
    Vaccine; 2010 Nov; 28(49):7803-9. PubMed ID: 20875496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tetanus despite preexisting antitetanus antibody.
    Berger SA; Cherubin CE; Nelson S; Levine L
    JAMA; 1978 Aug; 240(8):769-70. PubMed ID: 671711
    [No Abstract]   [Full Text] [Related]  

  • 39. Seroprevalence of tetanus toxoid antibody and booster vaccination efficacy in Japanese travelers.
    Mizuno Y; Yamamoto A; Komiya T; Takeshita N; Takahashi M
    J Infect Chemother; 2014 Jan; 20(1):35-7. PubMed ID: 24462422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transplacental dilution of tetanus antitoxins in Delhi.
    Singh J; Ichhpujani RL; Prabha S; Chandra R; Khare S; Grover SS; Datta KK
    J Trop Pediatr; 1997 Oct; 43(5):275-8. PubMed ID: 9364124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.